When Good Biomarkers go Bad

August 10, 2017

 

The 2016 LabLeaders Webinar Series continues with a unique opportunity for you to learn more about the role Procalcitonin (PCT) can play in recognizing and managing sepsis as well as the relevant operational features and institutional buy-in necessary to achieve maximum utility from this sepsis marker.

At the conclusion of this talk, attendees should be able to…

Summarize the requirements and implications of the new sepsis CMS core measure Explain the role of PCT in identifying and managing sepsis Decide on the required clinical performance necessary for PCT to be impactful, especially with regards to turnaround time (TAT) and test availability Understand how lab leaders should position PCT with key stakeholders to maximize adoption and clinical utility Please join Joshua Hayden, PhD, DABCC, FACB as he shares how PCT can help lab leaders bring more value to their labs and learn how to position it to key stakeholders to maximize adoption and clinical utility.

 

 

Previous Article
Unveiling the Future of Laboratory Medicine
Unveiling the Future of Laboratory Medicine

Next Article
Cultivating a Culture of Quality
Cultivating a Culture of Quality

Join Jennifer Dawson, MHA, DLM(ASCP)SLS, QIHC, QLC, as she presents the rationale for instituting a genuine...

×

LabLeaders.com has a new home. Tell us a bit about yourself.

Thank you!
Error - something went wrong!